Takeda Pharmaceutical TAK
NYSE TAK
$20.08 +0.47 (+2.37%)
As of: Oct 20, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) Assets (2017 - 2026)

Updated

Takeda Pharmaceutical (TAK) reported Assets of $98.27 billion for the quarter ended Jun 30, 2026, up 1.5% from $96.79 billion a year earlier but down 0.6% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Assets (2017 - 2026) Analysis & Trends

As of Mar 31, 2026, Takeda Pharmaceutical posted Assets of $103.05 billion, up 10.2% from the prior year.

  • Assets has a five-year compound annual growth rate of -3.3% (years ended Mar 2021 to Mar 2026).
  • By year, Assets came in at $93.54 billion in the year ended Mar 31, 2025 (-10.7%), $104.77 billion in the year ended Mar 31, 2024 (+1.4%), $103.32 billion in the year ended Mar 31, 2023 (-12.0%) and $117.38 billion in the year ended Mar 31, 2022 (-3.6%).
  • Five-year quarterly Assets spans a low of $93.39 billion in the quarter ended Mar 31, 2025 and a high of $113.39 billion in the quarter ended Mar 31, 2022.
  • Year over year, Assets has now increased in each of the last four quarters, with an average decline of 1.1% over the last eight quarters.
  • The high point for year-over-year Assets in five years was the quarter ended Mar 31, 2026 (growth of 5.9%); the low point was the quarter ended Mar 31, 2025 (a decline of 8.4%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $98.91 billion (quarter ended Mar 31, 2026), $100.12 billion (quarter ended Dec 31, 2025) and $98.21 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 201.06 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 135.12 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 115.83 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 49.36 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 201.13 Bn
10 Takeda Pharmaceutical 63.21 Bn 39.57 Bn 5.10 Bn 96.73 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 96.73 Bn
Mar 31, 2026 97.04 Bn
Dec 31, 2025 98.51 Bn
Sep 30, 2025 97.38 Bn
Jun 30, 2025 96.91 Bn
Mar 31, 2025 95.23 Bn
Dec 31, 2024 96.23 Bn
Sep 30, 2024 102.06 Bn
Jun 30, 2024 100.99 Bn
Mar 31, 2024 99.77 Bn
Dec 31, 2023 100.57 Bn
Sep 30, 2023 99.59 Bn
Jun 30, 2023 102.17 Bn
Mar 31, 2023 104.79 Bn
Dec 31, 2022 101.60 Bn
Sep 30, 2022 101.01 Bn
Jun 30, 2022 102.98 Bn
Mar 31, 2022 108.00 Bn
Dec 31, 2021 110.36 Bn
Jun 30, 2021 114.51 Bn
API Access

Takeda Pharmaceutical Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=TAK&period=max&api_key=YOUR_API_KEY